Navigation Links
BD Establishes $1.2 Million Fund for Haiti Earthquake Relief Efforts
Date:1/15/2010

FRANKLIN LAKES, N.J., Jan. 15 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it is donating $550,000 in support of relief efforts to assist the victims of the earthquake in Haiti. A financial donation of $250,000 will be split equally between the American Red Cross and the U.S. Fund for UNICEF. BD will distribute the remainder to AmeriCares, Catholic Medical Mission Board, Direct Relief International, Heart to Heart International, Partners in Health, Project HOPE and Save the Children.  

"With the massive devastation of this earthquake, BD is committed to working with our partners to support critical relief efforts," said Edward J. Ludwig, BD Chairman and Chief Executive Officer.  "On behalf of BD's 29,000 associates around the world, I extend our condolences and deepest sympathies to the people of Haiti and all affected by this tragedy."

BD also announced that it has authorized product donations of up to $500,000 of medical equipment, including needles, syringes, IV catheters and blood collection tubes, through the charitable organizations listed above.  The Company will also match donations from its associates worldwide to the U.S. Fund for UNICEF, up to a total of $150,000. This match is in addition to BD's traditional Matching Gift Program, which matches donations from U.S. associates to eligible nonprofit organizations. BD associates have already made individual contributions to many relief organizations for Haiti, and the corporate match will encourage further generosity.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

SOURCE BD (Becton, Dickinson and Company)

RELATED LINKS
http://www.bd.com

'/>"/>

SOURCE BD (Becton, Dickinson and Company)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FUJIFILM Establishes Medical Informatics Organization
2. First Candidate from Esperances Targeted Anti-cancer Platform, EP-100, Establishes Preclinical Proof of Concept
3. Pharmaxis Establishes Named Patient Program for Bronchitol
4. Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines
5. Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay
6. Henry Schein Works With Supplier Partners to Earmark $1 Million in Health Care Supplies for Haiti Earthquake Relief
7. Cardinal Health Helps Hospitals Save More Than $20 Million In Pharmaceutical Costs; Connect Low-Income Patients With Affordable Medications
8. Advanced Cardiac Therapeutics Completes $5 Million Financing
9. EnzySurge, Maker of DermaStream(R) Expanded its Recent Private Capital Round to $4.1 Million
10. Colorado-Based Spectranetics Corporation to Pay $5 Million to Resolve Allegations Relating to its Medical Devices
11. Vermillion Announces $43.05 Million Private Placement of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... TEL AVIV, Israel , March 28, 2017 /PRNewswire/ ... Israel . This new business entity, Emosis Ltd, headquartered ... to research and development of novel assays complementing the mother company ... relevant, locally support commercialization and sales development of Emosis kits. ... This strategic move starts ...
(Date:3/28/2017)... FRANCISCO , March 28, 2017 ...  is expected to reach a value of USD 4.5 ... Grand View Research, Inc. Proper closure of injured tissues ... structure and function. Postoperative leakages occur in 3% to ... complication. They are responsible for one third of postoperative ...
(Date:3/27/2017)... 2017 Summary This report ... and its partnering interests and activities since 2010. Description ... in-depth insight into the partnering activity of one of the ... reports are prepared upon purchase to ensure inclusion of the ... The report will be delivered in PDF format within 1 ...
Breaking Medicine Technology:
(Date:3/28/2017)... , ... March 28, 2017 , ... ... plans work, the Self-Funding Success website has recently developed and published an informational ... Plans ” was created based on common inquiries the site’s team of third ...
(Date:3/28/2017)... ... , ... A minimally invasive porcelain veneer is increasing in ... of Dental Laboratories (NADL) is informing dentists about the benefits of minimally invasive ... laboratories and technicians that create these veneers. , According to National Board ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Public relations pros ... across a variety of business channels. , While many results are clear, much of ... relations program. , When it comes to measurement, firms should always take an ...
(Date:3/28/2017)... ... March 28, 2017 , ... Silicon Valley Hair Institute, the San Francisco ... blog post about women’s hair loss. Although hair transplant procedures can be seen as ... Menopause or genetics can be two reasons a woman may see her hair thinning. ...
(Date:3/28/2017)... St. Louis, MO (PRWEB) , ... March 28, ... ... high levels of job satisfaction in their profession as their value increases in ... a company that provides resources such as job boards, career fairs, and candidate ...
Breaking Medicine News(10 mins):